Related Experiment Video
Updated: May 23, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Retrieval Augmented Therapy Suggestion for Molecular Tumor Boards: Algorithmic Development and Validation Study
Eliza Berman1, Holly Sundberg Malek2, Michael Bitzer3
1Center for Digital Health, University Hospital Tuebingen, Tuebingen, Germany.
Background:
Molecular tumor boards (MTBs) require intensive manual investigation to generate optimal treatment recommendations for patients. Large language models (LLMs) can catalyze MTB recommendations, decrease human error, improve accessibility to care, and enhance the efficiency of precision oncology.
Objective:
In this study, we aimed to investigate the efficacy of LLM-generated treatments for MTB patients. We specifically investigate the LLMs' ability to generate evidence-based treatment recommendations using PubMed references.
Methods:
We built a retrieval augmented generation pipeline using PubMed data. We prompted the resulting LLM to generate treatment recommendations with PubMed references using a test set of patients from an MTB conference at a large comprehensive cancer center at a tertiary care institution. Members of the MTB manually assessed the relevancy and correctness of the generated responses.
Results:
A total of 75% of the referenced articles were properly cited from PubMed, while 17% of the referenced articles were hallucinations, and the remaining were not properly cited from PubMed. Clinician-generated LLM queries achieved higher accuracy through clinician evaluation than automated queries, with clinicians labeling 25% of LLM responses as equal to their recommendations and 37.5% as alternative plausible treatments.
Conclusions:
This study demonstrates how retrieval augmented generation-enhanced LLMs can be a powerful tool in accelerating MTB conferences, as LLMs are sometimes capable of achieving clinician-equal treatment recommendations. However, further investigation is required to achieve stable results with zero hallucinations. LLMs signify a scalable solution to the time-intensive process of MTB investigations. However, LLM performance demonstrates that they must be used with heavy clinician supervision, and cannot yet fully automate the MTB pipeline.
More Related Videos
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...